LRCX AI Stock Analysis – Buy, Hold, or Avoid?
Lam Research Corporation (LRCX)
Fundamentals
Lam Research (LRCX) demonstrates robust financial performance marked by accelerating revenue and earnings growth over the past year. Consistent quarterly beats on both revenue and EPS reinforce the company's execution strength, while margin expansion suggests improved operating leverage. However, a stretched valuation and high P/E ratio could moderate near-term upside.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
23.76% YoY
Q1 2026
Net Income
37.18% YoY
Q1 2026
Net Margin
Q1 2026
Growth Metrics
Profitability Metrics
Technical Analysis
LRCX is in a strong bullish uptrend, supported by a recent golden cross and price well above key moving averages. Momentum is solid though the RSI indicates the stock is nearing overbought territory, suggesting potential short-term consolidation is possible. Key technical support lies in the $357-$390 region, with resistance near the 52-week high around $400-$401.
No extreme reading
Price in uptrend
Strong trend active
50 above 200 - bullish
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Lam Research (LRCX) demonstrates robust financial performance marked by accelerating revenue and earnings growth over the past year. Consistent quarterly beats on both revenue and EPS reinforce the company's execution strength, while margin expansion suggests improved operating leverage. However, a stretched valuation and high P/E ratio could moderate near-term upside.
Latest Earnings
Q1 2026 Earnings (Mar 29, 2026)
Earnings Per Share (EPS)
Actual
$1.47
Estimated
$1.36
Surprise
+$0.11
Surprise %
+8.09%
Revenue
Actual
$5.84B
Estimated
$5.75B
Surprise
+$91.14M
Surprise %
+1.58%
Historical Earnings
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $1.47 | $1.27 | $1.26 | $1.33 | $1.04 | $0.91 | $0.86 | $0.81 |
| EPS (Estimated) | $1.36 | $1.17 | $1.22 | $1.21 | $1.00 | $0.88 | $0.81 | $0.76 |
| EPS Surprise | +$0.11 | +$0.10 | +$0.04 | +$0.12 | +$0.04 | +$0.03 | +$0.05 | +$0.05 |
| % Diff | +8.1% | +8.5% | +3.3% | +9.9% | +4.0% | +3.6% | +6.2% | +6.9% |
| Revenue | ||||||||
| Revenue (Actual) | $5.84B | $5.34B | $5.32B | $5.17B | $4.72B | $4.38B | $4.17B | $3.87B |
| Revenue (Estimated) | $5.75B | $5.23B | $5.22B | $5B | $4.64B | $4.32B | $4.06B | $3.82B |
| Revenue Surprise | +$91.14M | +$111.56M | +$101.04M | +$167.42M | +$77.41M | +$58.58M | +$110.66M | +$49.21M |
| % Diff | +1.6% | +2.1% | +1.9% | +3.3% | +1.7% | +1.4% | +2.7% | +1.3% |
Valuation
Lam Research Corporation (LRCX) currently trades at a pronounced premium compared to its historical averages and sector peers, reflecting strong growth expectations tied to semiconductor industry dynamics and AI-driven demand. While earnings and revenue growth remain robust, the lofty valuation multiples suggest the market is pricing in sustained high growth and operational excellence. Analyst consensus leans positive, but a notable divergence in price targets indicates valuation risks remain significant.
Valuation Metrics
Sentiment & Analyst Ratings
The overall sentiment for Lam Research Corporation (LRCX) is optimistic, driven by strong revenue growth, robust Q3 FY26 results, and continued demand in the semiconductor equipment sector, especially fueled by AI-related chip production. While the stock trades at a high valuation with some caution about overvaluation and geopolitical risks, analyst upgrades and positive social media buzz reinforce a bullish outlook among investors.
Analyst Recommendations
Risk Assessment
Lam Research exhibits strong financial health with robust liquidity and manageable leverage, supported by solid earnings growth driven by AI and semiconductor capital spending. However, significant risks such as revenue concentration in China, cyclical industry dynamics, and margin pressures from competitive and regulatory factors temper the investment outlook. These factors present a moderate overall risk, balanced by strong market positioning and growth potential.
Liquidity & Solvency
Frequently Asked Questions about LRCX
AI Answers: Common Questions About LRCX
Get AI-powered answers to the questions investors ask most about Lam Research Corporation
LRCX is fundamentally strong and in a bullish trend, but currently trades at a high P/E of 73.68 and near its 52-week high ($401). While the long-term outlook is positive, short-term entry is best on pullbacks or consolidation toward support ($357-$390) to mitigate overvaluation risk.
Unless your thesis has changed or you are highly risk-averse, there is no strong reason to sell now: fundamentals are robust, technicals remain bullish, and sentiment is positive. However, consider trimming if overexposed or if price fails to hold above key support levels.
Key risks include high revenue dependence on China (exposing LRCX to regulatory/geopolitical shocks), sector cyclicality, and premium valuation (P/E 73.68, EV/EBITDA well above peers) that could lead to sharp corrections if growth disappoints. Liquidity and solvency are strong, but volatility is moderate and in line with industry.
Technically, immediate resistance is at $400-$401; a breakout could target $475 to $600 in a continued uptrend. Analyst targets range from $335 to $575, with most recent upgrades clustering in the $400-$500 range. Support is strong at $357-$390.
LRCX is overvalued relative to historical and sector averages, with a P/E of 73.68 and high EV/EBITDA and P/B multiples. The premium is justified by growth and profitability, but leaves the stock vulnerable to any slowdown or negative surprises.
The company is fundamentally strong: revenue growth is 23.7% YoY, EPS up 44%, gross margin near 50%, net margin 31%+, ROE over 32%, and liquidity ratios (current 2.5+, quick 1.77) are excellent. Balance sheet is healthy and cash generation is robust.
Technical analysis is bullish: price is above all major SMAs, a golden cross is confirmed, and volume is strong. RSI at 68.6 suggests near-term overbought conditions, so a short-term pullback or consolidation is possible before further upside.
Key catalysts include upcoming earnings (with a history of beats), continued AI/data center chip demand, new product launches, and any easing of China-related regulatory risks. Watch for volume spikes, analyst upgrades, and macro news impacting semiconductor capex.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.